Diligence memo · auto-generated · as of July 2, 2026

Algernon Health Inc.

Algernon Health Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Algernon Health Inc. operates in Healthtech, based in VANCOUVER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Algernon Health Inc. has raised $1.5M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.1M on 2015-05-15.

Most recent recorded round closed around 2025-11-14.

Valuation (modeled)modeled

Provath models Algernon Health Inc. at approximately $623K (range $212K–$1.1M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.13× the median modeled value of Seed Healthtech companies in 2025–2027 (77 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 42 months.

Last raise 8 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 2.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 34% of Healthtech peers (2138 compared).

Modeled value ranks above 10% of those peers.

Closest niche peers: Headstart Health, Inc., eMAX Health 2.0 LLC, Ezer Health Holdings, Llc, Helius Medical Technologies, Inc., LaaSy Health HoldCo Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.